Administration of Dopexamine, A New Adrenergic Agent, in Cardiorespiratory Failure

Jean Louis Vincent; Charles Reuse; Robert J. Kahn

doi:10.1378/chest.96.6.1233

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1984

A complete system for transportation of critically ill patients with acute cardiorespiratory failure.

Jean Louis Vincent, Philippe Dufaye, Robert J. Kahn

Article1992

Addition of enoximone to adrenergic agents in the management of severe heart failure

Jean Louis Vincent, Marc Léon, Jacques Berré, Christian Mélot, Robert J. Kahn

Article1990

PGE1 ADMINISTRATION IN RIGHT VENTRICULAR FAILURE FOLLOWING CARDIAC TRANSPLANTATION

Jean Louis Vincent, Eric Carlier, Serge Brimioulle, Michael R. Pinsky, Philippe Lejeune, Robert Naeije, Jacques Goldstein, Robert J. Kahn, Jean-Louis LeClerc, G Primo

Article1994

Fludarabine phosphate: a new active agent in hematologic malignancies.

Michael J. Keating, Susan O’Brien, William Plunkett, L. E. Robertson, Varsha Gandhi, Elihu H. Estey, Meletios A Dimopoulos, Fernando Cabanillas, A. Kemena, Hagop M. Kantarjian

Article1979

Alpha1-adrenergic receptors in guinea pig myocardium: Identification by binding of a new radioligand, (3H)-prazosin

Joel S. Karliner, Peter J Barnes, C.A. Hamilton, C. T. Dollery